Full View

Bioluminescent reporters for rapid mechanism of action assessment in tuberculosis drug discovery

K Naran, A Moosa, CE Barry III… - Antimicrobial Agents …, 2016 - Am Soc Microbiol
The tuberculosis (TB) drug discovery pipeline is fueled by compounds identified in whole-
cell screens against the causative agent, Mycobacterium tuberculosis. Phenotypic screening …
被引用次数：47 相关文章

Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery

K Naran, A Moosa, CE Barry III, HIM Boshoff… - Antimicrobial Agents …, 2016 - hero.epa.gov
The tuberculosis (TB) drug discovery pipeline is fueled by compounds identified in whole-
cell screens against the causative agent, Mycobacterium tuberculosis. Phenotypic screening …

Bioluminescent reporters for rapid mechanism of action assessment in tuberculosis drug discovery.

K Naran, A Moosa, CEIII Barry, HIM Boshoff, V Mizrahi… - 2016 - cabidigitallibrary.org
The tuberculosis (TB) drug discovery pipeline is fueled by compounds identified in whole-
cell screens against the causative agent, Mycobacterium tuberculosis. Phenotypic screening …
[PDF] researchgate.net

[PDF][PDF] Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery

K Naran, A Moosa, CE Barry III, HIM Boshoff, V Mizrahi… - 2016 - researchgate.net
The tuberculosis (TB) drug discovery pipeline is fueled by compounds identified in whole-
cell screens against the causative agent, Mycobacterium tuberculosis. Phenotypic screening …

Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.

K Naran, A Moosa, CE Barry 3rd, HI Boshoff… - Antimicrobial Agents …, 2016 - europepmc.org
The tuberculosis (TB) drug discovery pipeline is fueled by compounds identified in whole-
cell screens against the causative agent, Mycobacterium tuberculosis. Phenotypic screening …
[HTML] nih.gov

[HTML][HTML] Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery

K Naran, A Moosa, CE Barry III… - Antimicrobial Agents …, 2016 - ncbi.nlm.nih.gov
The tuberculosis (TB) drug discovery pipeline is fueled by compounds identified in whole-
cell screens against the causative agent, Mycobacterium tuberculosis. Phenotypic screening …

Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery

K Naran, A Moosa, CE Barry 3rd… - Antimicrobial …, 2016 - pubmed.ncbi.nlm.nih.gov
The tuberculosis (TB) drug discovery pipeline is fueled by compounds identified in whole-
cell screens against the causative agent, Mycobacterium tuberculosis Phenotypic screening …

Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery

K Naran, A Moosa, CE Barry, HIM Boshoff… - Antimicrobial Agents …, 2016 - cir.nii.ac.jp
抄録< jats: title> ABSTRACT</jats: title>< jats: p> The tuberculosis (TB) drug discovery
pipeline is fueled by compounds identified in whole-cell screens against the causative …